Current Ratio of Enliven Therapeutics, Inc. from 30 Sep 2020 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Enliven Therapeutics, Inc. quarterly Current Ratio in % history and change rate from 30 Sep 2020 to 30 Sep 2025.
  • Enliven Therapeutics, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 2662%, a 97% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Enliven Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 2662% +1309% +97% 30 Sep 2025
Q2 2025 2262% +863% +62% 30 Jun 2025
Q1 2025 1779% +178% +11% 31 Mar 2025
Q4 2024 1587% -335% -17% 31 Dec 2024
Q3 2024 1353% -862% -39% 30 Sep 2024
Q2 2024 1398% -872% -38% 30 Jun 2024
Q1 2024 1601% -335% -17% 31 Mar 2024
Q4 2023 1922% +654% +52% 31 Dec 2023
Q3 2023 2215% +487% +28% 30 Sep 2023
Q2 2023 2271% +739% +48% 30 Jun 2023
Q1 2023 1936% +586% +43% 31 Mar 2023
Q4 2022 1268% -182% -13% 31 Dec 2022
Q3 2022 1727% +384% +29% 30 Sep 2022
Q2 2022 1532% +109% +7.7% 30 Jun 2022
Q1 2022 1351% -389% -22% 31 Mar 2022
Q4 2021 1449% -473% -25% 31 Dec 2021
Q3 2021 1344% -473% -26% 30 Sep 2021
Q2 2021 1422% 30 Jun 2021
Q1 2021 1739% 31 Mar 2021
Q4 2020 1922% 31 Dec 2020
Q3 2020 1817% 30 Sep 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.